This bill states the Sense of Congress that medication abortion is an extremely safe medical treatment and that the Food and Drug Administration (FDA) approval of medication abortion preempts State laws that would require in-person dispensing or that prohibit or restrict prescribing or dispensing medication abortion by telehealth. The provision was introduced in the House on May 11, 2026, and referred to the Committee on Energy and Commerce.
The bill expresses Congress's view that FDA approval of medication abortion should override State requirements forcing in-person dispensing and should prevent States from banning or restricting telehealth prescribing or dispensing for medication abortion. The bill text itself sets out this statement of view and does not include detailed steps for changing regulations or enforcement mechanisms.
No publicly available information.
The bill says medication abortion is an extremely safe medical treatment and that the FDA, based on scientific evidence, appropriately approved it. It also says that the FDA approval should preempt State laws that require in-person dispensing or that ban or restrict telehealth for medication abortion.
No publicly available information.